Human Molecular Genetics Biochemistry

Research output

Research output per year 1962 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2023

• 177706 Citations
• 179 h-index
• 2207 Article
• 372 Review article
• 91 Comment/debate
• 77 Editorial
• 181 More
  • 66 Chapter
  • 43 Letter
  • 34 Short survey
  • 15 Meeting Abstract
  • 12 Conference contribution
  • 6 Book
  • 3 Foreword/postscript
  • 2 Conference article

Research output per year

Research output per year

Search results

• 2020

  AAV Gene Therapy Rescues Hearing in a Mouse Model of SYNE4 Deafness

  Taiber, S., Cohen, R., Yizhar-Barnea, O., Sprinzak, D., Holt, J. R. & Avraham, K. B., Oct 2020, In: Transgenic Research. 29, SUPPL 1, p. 23-23

  Research output: Contribution to journal › Meeting Abstract › peer-review

• CRISPR/Cas9 Mice Genome Editing to Study New Human Deafness Genes

  Abu-Rayyan, A., Bordeynik-Cohen, M., Taiber, S., Koffler-Brill, T., Rosen, E., Carlson, R., Haffner, R., Kanaan, M., King, M-C. & Avraham, K. B., Oct 2020, In: Transgenic Research. 29, SUPPL 1, p. 11-11

  Research output: Contribution to journal › Meeting Abstract › peer-review
• 2018

  CRISPR/Cas9 genome editing to create mouse models for human deafness

  Borodnik-Cohen, M., Danial-Faran, N., Yizhar-Barnea, O., Noy, Y., Koffler, T., Shalev, S., Haffner, R. & Avraham, K. B., 9 Mar 2018, In: Human Genomics. 12

  Research output: Contribution to journal › Meeting Abstract › peer-review

• Genetic and transcriptional instability alters cell line drug response

  Ben-David, U., Siranosian, B., Ha, G., Tang, H., Lyons, N. J., Burns, R., Nag, A., Cimini, B., Tsvetkov, P., Tubelli, A. A., Wong, B., Thorner, A. R., Bittker, J., Meyerson, M., Beroukhim, R. & Golub, T. R., Jul 2018, In: Cancer Research. 78, 13

  Research output: Contribution to journal › Meeting Abstract › peer-review
• 2017

  RNA-SEQUENCING OF BIPOLAR DISORDER PATIENTS LYMPHOBLASTOID CELL LINES IMPLICATES A NOVEL NEUROTROPHIC FACTOR IN THE EFFICACY OF LITHIUM AS MOOD STABILIZING DRUG

  Milanesi, E., Voinsky, I., Hadar, A., Maj, C., Kelsoe, J. R., Shekhtman, T., Zandi, P., Goes, F., Potash, J. B., Greshovits, M., Gilad, S., Gennarelli, M., Schulze, T. G. & Gurwitz, D., Oct 2017, In: European Neuropsychopharmacology. 27, p. S391-S392

  Research output: Contribution to journal › Meeting Abstract › peer-review
• 2016

  Pluripotent genes role in normal melanocyte lineage commitment and malignant transformation

  Sheinboim, D., Maza, I., Dror, I., Hanna, J. & Levy, C., Jul 2016, In: European Journal of Cancer. 61, p. S109-S109

  Research output: Contribution to journal › Meeting Abstract › peer-review

• The landscape of chromosomal aberrations in mouse models of breast cancer reveals driver-specific routes to tumor development

  Ben-David, U., Ha, G., Khadka, P., Jin, X., Franke, L. & Golub, T. R., Jul 2016, In: Cancer Research. 76

  Research output: Contribution to journal › Meeting Abstract › peer-review
• 2011

  Mesenchymal stem cells induced to secrete neurotrophic factors attenuate excitotoxicity: autotrasplantation stem-cells based therapeutic potential for Huntington's disease

  Sadan, O., Shemesh, N., Barzilay, R., Dadon, M., Blumenfeld-Katzir, T., Assaf, Y., Yeshurun, M., Djaldetti, R., Cohen, Y., Melamed, E. & Offen, D., 2011, In: Journal of Molecular Neuroscience. 45 Suppl 1, p. S100 1 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review
• 2010

  B15 Rat bone marrow derived mesenchymal stem cells post differentiation to neurotrophic factor secreting cells migrate towards quinolinic acid lesion

  Sadan, O., Shemesh, N., Cohen, Y., Melamed, E. & Offen, D., 2010, In: Journal of Neurology, Neurosurgery and Psychiatry. 81, Suppl 1, p. A15-A16

  Research output: Contribution to journal › Meeting Abstract › peer-review

  • Quinolinic Acid 100%
  • Nerve Growth Factors 76%
  • Mesenchymal Stem Cells 63%
  • Cell Differentiation 57%
  • PKH 26 16%

• Human Derived Neurotrophic Factors Secreting Mesenchymal Stem Cells Attenuate Quinolinic Acid-Induced Striatal Lesion: A Model of Huntington’s Disease

  Sadan, O., Barhum, Y., Shemesh, N., Cohen, Y., Offen, D. & Melamed, E., 2010, In: Human Gene Therapy. 21, 5, p. 653-653

  Research output: Contribution to journal › Meeting Abstract › peer-review

• I11 Longitudinal MRI and MRSI characterisation of the quinolinic acid rat model for excitotoxicity: unique recovery of N-acetyl aspartate levels

  Sadan, O., Shemesh, N., Melamed, E., Offen, D. & Cohen, Y., 2010, In: Journal of Neurology, Neurosurgery and Psychiatry. 81, Suppl 1, p. A39-A39

  Research output: Contribution to journal › Meeting Abstract › peer-review

  • Quinolinic Acid 100%
  • N-acetylaspartate 90%
  • Corpus Striatum 13%
  • Coloring Agents 11%
  • Statistics 10%

• Induced Neurotrophic Factors Secreting Mesenchymal Stromal Cells Are Beneficial in Animal Models of Parkinson’s Disease

  Sadan, O., Barhum, Y., Shemesh, N., Cohen, Y., Offen, D. & Melamed, E., 2010, In: Human Gene Therapy. 21, 5, p. 653-654

  Research output: Contribution to journal › Meeting Abstract › peer-review
• 2004

  Aromatic inhibition of amyloid formation by the human islet amyloid polypeptide

  Porat, Y., Efrat, S. & Gazit, E., Jan 2004, In: Biophysical Journal. 86, 1, p. 339A-340A

  Research output: Contribution to journal › Meeting Abstract › peer-review
• 2003

  Structural and Conformational investigations of amyloidogenic sequences: MD studies of IAPP peptides

  Zanuy, D., Gazit, E. & Nussinov, R., Feb 2003, In: Biophysical Journal. 84, 2, p. 155A-155A

  Research output: Contribution to journal › Meeting Abstract › peer-review
• 1987

  LOCALIZATION OF X-LINKED ALBINISM-DEAFNESS SYNDROME (ADFN) TO XQ BY LINKAGE WITH DNA MARKERS

  LITVAK, G., SANDKUYL, L., OTT, J., BUCHRIS, V., HILDESHEIMER, M. & SHILOH, Y., 1987, In: Cytogenetics and Cell Genetics. 46, 1-4, p. 652-652

  Research output: Contribution to journal › Meeting Abstract › peer-review